Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cardiol Therapeutics (CRTPF)

Cardiol Therapeutics (CRTPF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Cardiol Therapeutics' Board of Directors Appoints Dr. Guillermo Torre-Amione as Chairman

Oakville, Ontario--(Newsfile Corp. - July 7, 2021) - Cardiol Therapeutics Inc.()()()(""""), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment...

CRTPF : 2.2500 (+6.52%)
CRDL.TO : 2.83 (+6.79%)
Cardiol Therapeutics Reports Results of 2021 Annual General and Special Meeting

Oakville, Ontario--(Newsfile Corp. - June 30, 2021) - Cardiol Therapeutics Inc.()()()(""""), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the...

CRTPF : 2.2500 (+6.52%)
CRDL.TO : 2.83 (+6.79%)
Cardiol Therapeutics to Webcast Virtual Annual General and Special Meeting on June 29th at 4:30 p.m. EDT

Oakville, Ontario--(Newsfile Corp. - June 28, 2021) - Cardiol Therapeutics Inc.()()()(""""), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the...

CRTPF : 2.2500 (+6.52%)
CRDL.TO : 2.83 (+6.79%)
Recent Surge for Intellectual Property & Patents in Psychedelic Therapies & Drug Development

/PRNewswire/ -- The modern psychedelic renaissance has empirically proven that psychedelic drugs are going to revolutionize mental health treatment. Before these incredibly promising medicines can get...

OILFF : 0.1849 (+3.41%)
OILS.CN : 0.230 (+4.55%)
MNMD : 3.06 (+0.99%)
LKYSF : 0.7778 (+4.08%)
NUMI.VN : 0.970 (+4.30%)
FTRPF : 5.7460 (-2.32%)
FTRP.CN : 5.550 (+1.46%)
CRTPF : 2.2500 (+6.52%)
CRDL.TO : 2.83 (+6.79%)
Cardiol Therapeutics Announces First Patient Enrolled in LANCER, a Phase II/III Outcomes Trial in High-Risk Patients Hospitalized with COVID-19

Oakville, Ontario--(Newsfile Corp. - April 28, 2021) - ()()()(or the), a clinical-stage biotechnology companyfocused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular...

CRDL.TO : 2.83 (+6.79%)
CRTPF : 2.2500 (+6.52%)
Cardiol Therapeutics Announces Topline Results from Phase I Single and Multiple Ascending Dose Clinical Trial of CardiolRx(TM)

Oakville, Ontario--(Newsfile Corp. - April 12, 2021) - ()()()(or the), a clinical-stage biotechnology companyfocused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular...

CRDL.TO : 2.83 (+6.79%)
CRTPF : 2.2500 (+6.52%)
Cardiol Therapeutics Announces Filing of 2020 Year-End Financial Statements and MD&A

Oakville, Ontario--(Newsfile Corp. - April 1, 2021) - () ()()(""or the ""),a clinical-stage biotechnology companyfocused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular...

CRDL.TO : 2.83 (+6.79%)
CRTPF : 2.2500 (+6.52%)
Cardiol Therapeutics Appoints Dr. Andrew Hamer as New Chief Medical Officer

Oakville, Ontario--(Newsfile Corp. - March 30, 2021) - () ()()(""or the ""),a clinical-stage biotechnology companyfocused on developing innovative anti-inflammatory therapies for the treatment of cardiovascular...

AMGN : 241.54 (-0.38%)
CRDL.TO : 2.83 (+6.79%)
CRTPF : 2.2500 (+6.52%)
Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over $10 Million from Exercise of Warrants and Options

Oakville, Ontario--(Newsfile Corp. - March 2, 2021) - () () () ("" or the ""), a clinical-stage biotechnology company focused on developing innovative anti-inflammatory therapies for the treatment of...

CRDL.TO : 2.83 (+6.79%)
CRTPF : 2.2500 (+6.52%)
Cardiol Therapeutics Announces Formation of Data Safety Monitoring and Clinical Endpoint Committees for Phase II/III Outcomes Trial in High-Risk Patients Hospitalized with COVID-19

Oakville, Ontario--(Newsfile Corp. - January 21, 2021) - () () ("" or the ""), a clinical-stage biotechnology company focused on the research and clinical development of anti-inflammatory therapies for...

CRTPF : 2.2500 (+6.52%)
CRDL.TO : 2.83 (+6.79%)
Cardiol Therapeutics to Participate in Upcoming Virtual Investor Conferences

Oakville, Ontario--(Newsfile Corp. - January 7, 2021) - () () ("" or the ""), a clinical-stage biotechnology company focused on developing innovative therapies for inflammatory heart disease, announced...

CRTPF : 2.2500 (+6.52%)
CRDL.TO : 2.83 (+6.79%)
Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx(TM)

Oakville, Ontario--(Newsfile Corp. - December 22, 2020) - () () ("" or the ""), a clinical-stage biotechnology company focused on developing innovative therapies for inflammatory heart disease, is pleased...

CRTPF : 2.2500 (+6.52%)
CRDL.TO : 2.83 (+6.79%)
Cardiol Therapeutics Appoints Worldwide Clinical Trials as CRO for the Company's Phase II/III Outcomes Trial in High-Risk Patients Hospitalized with COVID-19

() () ("" or the ""), a clinical-stage biotechnology company focused on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease ("CVD"), announces...

CRTPF : 2.2500 (+6.52%)
CRDL.TO : 2.83 (+6.79%)
Cardiol Therapeutics' Cortalex(TM) CBD Now Available Exclusively Online at Medical Cannabis by Shoppers Inc.

() () ("" or the ""), a clinical-stage biotechnology company focused on developing innovative therapies for inflammatory heart disease, is pleased to announce the commercial introduction of Cortalex, a...

CRDL.TO : 2.83 (+6.79%)
CRTPF : 2.2500 (+6.52%)
FDA Approves Landmark COVID/Heart/CBD Clinical Trial -- SECFilings.com

Redondo Beach, California--(Newsfile Corp. - September 30, 2020) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the publication...

CRDL.TO : 2.83 (+6.79%)
CRTPF : 2.2500 (+6.52%)
Cardiol Therapeutics Receives FDA Approval for Investigational New Drug (IND) Application for Phase II/III COVID-19 Trial

Oakville, Ontario--(Newsfile Corp. - September 25, 2020) - () () ("" or the ""), a clinical-stage biotechnology company focused on developing innovative therapies for inflammatory heart disease, is pleased...

CRDL.TO : 2.83 (+6.79%)
CRTPF : 2.2500 (+6.52%)
Cannabidiol Phase 1 Clinical Trial Launches, Targeting Inflammatory Heart Condition -- SECFilings.com

Redondo Beach, California--(Newsfile Corp. - September 16, 2020) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces the publication...

CRDL.TO : 2.83 (+6.79%)
CRTPF : 2.2500 (+6.52%)
Cardiol Therapeutics to Present at the H.C. Wainwright Virtual 22nd Annual Global Investment Conference

Oakville, Ontario--(Newsfile Corp. - September 15, 2020) - () () ("" or the ""), a leader in the development of pharmaceutical cannabidiol formulations for the treatment of cardiovascular diseases, including...

CRDL.TO : 2.83 (+6.79%)
CRTPF : 2.2500 (+6.52%)
Cardiol Therapeutics Initiates Health Canada Approved Phase 1 Clinical Study of CardiolRx(TM)

Oakville, Ontario--(Newsfile Corp. - August 26, 2020) - () () ("" or the ""), a leader in the development of pharmaceutical cannabidiol formulations for the treatment of cardiovascular diseases, including...

CRDL.TO : 2.83 (+6.79%)
CRTPF : 2.2500 (+6.52%)
Global Pandemic Creating Opportunities for Drug Companies to Earn Positive Market Attention

, /PRNewswire/ -- In the last 18 years, viral disease epidemics have across the globe. Today's pandemic is quickly adding to the number of deaths while seriously disrupting economies, businesses, and...

GILD : 68.29 (-2.21%)
AZN : 57.24 (-0.69%)
PFE : 42.81 (+0.05%)
LLY : 243.50 (-0.75%)
CRDL.TO : 2.83 (+6.79%)
CRTPF : 2.2500 (+6.52%)

Barchart Exclusives

When Weather and Weather Derivatives Diverge
A look at the softs complex Friday morning shows us markets aren't looking at weather in Brazil to close out the month. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar